Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy

Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy

Chimeric antigen receptor (CAR) engineering of natural killer (NK) cells is an attractive research field in tumor immunotherapy. While CAR is genetically engineered to express certain molecules, it retains the intrinsic ability to recognize tumor cells through its own receptors. Additionally, NK cel...

Full description

Bibliographic Details
Main Authors: Kangdi Yang, Yuze Zhao, Guanqun Sun, Xu Zhang, Jinjin Cao, Mingcong Shao, Xijun Liang, Lina Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
CAR-NK cell
tumor immunotherapy
immune checkpoint inhibitors
clinical
prospect
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1081546/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1081546/full

Similar Items